Type 2 Diabetes Linked to a 53% Higher Risk of Alzheimer's Disease, Study Finds

A new systematic review and meta-analysis published in Alzheimer's Research & Therapy has found that type 2 diabetes is linked to a 53% higher adjusted relative risk of developing Alzheimer's disease compared to individuals without the condition. Led by researchers at Curtin University, the paper evaluated 40 previous studies to better understand the connection between metabolic health and neurodegeneration.

To quantify the burden, the investigation estimated that out of every 1,000 people living with type 2 diabetes followed over the course of a year, an average of 4.7 would go on to develop Alzheimer's. Dr. Emmanuel Adewuyi, an NHMRC investigator fellow at the Curtin School of Population Health and study author, noted that previous literature often grouped various types of diabetes and dementia together. By narrowing their focus specifically to type 2 diabetes and Alzheimer's disease, the team was able to provide a clearer picture of both relative risk and the rate of new cases.

While the findings highlight a notable statistical connection, observational reviews of this nature identify associations rather than direct cause and effect. Experts recommend discussing any personal health concerns or preventive strategies with a qualified physician.

• What to know: Type 2 diabetes is associated with a 53% increase in the relative risk of Alzheimer's disease.
• Study scope: The findings are based on a systematic review and meta-analysis of 40 separate studies.
• Incidence rate: Roughly 4.7 out of 1,000 individuals with type 2 diabetes developed Alzheimer's annually in the estimated projection.